--- title: "Multiple shareholders and directors of BRILLIANCE TECH. plan to reduce their holdings by no more than 2.0316%" type: "News" locale: "en" url: "https://longbridge.com/en/news/258704473.md" description: "BRILLIANCE TECH. announced that shareholders and directors holding more than 5% of the shares, Kang Lu, Zhang Yansheng, Xu Lianping, and Yang Hanjie, plan to collectively reduce their holdings by 6.0655 million shares, accounting for 2.0316% of the company's total share capital" datetime: "2025-09-24T12:20:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/258704473.md) - [en](https://longbridge.com/en/news/258704473.md) - [zh-HK](https://longbridge.com/zh-HK/news/258704473.md) generator: "portal-rs" --- # Multiple shareholders and directors of BRILLIANCE TECH. plan to reduce their holdings by no more than 2.0316% According to the Zhitong Finance APP, BRILLIANCE TECH. (300542.SZ) announced that the company received notification letters regarding the share reduction plan from Mr. Kang Lu, a shareholder and director holding more than 5% of the shares, Mr. Zhang Yansheng, a shareholder and director holding more than 5% of the shares, Mr. Xu Lianping, a shareholder holding more than 5% of the shares, and Mr. Yang Hanjie, a director. Due to personal funding needs, they plan to reduce their directly held shares in the company. The aforementioned shareholders plan to collectively reduce 6.0655 million shares, accounting for 2.0316% of the company's total share capital ### Related Stocks - [300542.CN](https://longbridge.com/en/quote/300542.CN.md) ## Related News & Research - [Meta Wolf’s Lubanco Pte. Ltd., closely associated with Supervisory Board member Thomas Wolf, buys shares for EUR 1,402.5](https://longbridge.com/en/news/296554860.md) - [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md) - [CARsgen FY26 H1 net loss narrows to RMB 70.84 million; revenue rises 21.49% to RMB 61.92 million](https://longbridge.com/en/news/296243257.md) - [BYD Fang Cheng Bao launches Tai 7 DM long-range version with over 300 km EV range](https://longbridge.com/en/news/296234132.md) - [CTT Pharmaceutical CEO Ryan Khouri acquires 10,000 common shares for $590](https://longbridge.com/en/news/296370127.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**